Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
PAVmed Inc. (PAVM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/29/2021 |
GN
| Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics' Board of Directors |
| 04/27/2021 |
GN
| Global Industry Executive Debbie White Joins PAVmed Board of Directors |
| 04/08/2021 |
GN
| PAVmed to Present at the 20th Annual Needham Healthcare Conference |
| 03/10/2021 |
GN
| PAVmed to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference |
| 03/03/2021 |
GN
| PAVmed Retires Convertible Debt |
| 03/01/2021 |
GN
| PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors |
| 02/25/2021 |
GN
| PAVmed Announces Closing of its Public Offering of Common Stock |
| 02/23/2021 |
GN
| PAVmed Announces Pricing of $45 Million Public Offering of Common Stock |
| 02/22/2021 |
GN
| PAVmed Announces Proposed Public Offering of Common Stock |
| 02/22/2021 |
GN
| PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results |
| 02/18/2021 |
GN
| PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST |
| 02/16/2021 |
GN
| First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed's CarpX® Device |
| 02/09/2021 |
GN
| PAVmed to Hold Business Update Conference Call on February 22, 2021 |
| 01/08/2021 |
GN
| PAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules |
| 01/06/2021 |
GN
| PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules |
| 12/22/2020 |
GN
| PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering |
| 12/11/2020 |
GN
| PAVmed Announces Registered Direct Offering of its Common Stock |
| 11/17/2020 |
GN
| PAVmed Reports Third Quarter 2020 Financial Results and Provides Business Update |
| 11/02/2020 |
GN
| PAVmed to Hold Business Update Conference Call on November 17, 2020 |
| 09/08/2020 |
GN
| PAVmed to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 15, 2020 |
| 08/18/2020 |
GN
| PAVmed Reports Second Quarter 2020 Financial Results and Provides Business Update |
| 08/06/2020 |
GN
| PAVmed Secures $7 Million Convertible Note Financing |
| 07/28/2020 |
GN
| PAVmed to Hold Business Update Conference Call on August 18, 2020 |
| 06/17/2020 |
GN
| PAVmed to Join the Russell 2000® and Russell 3000® Indexes |
| 06/15/2020 |
GN
| Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor |
| 06/15/2020 |
GN
| ContraFect Announces Appointment of Lishan Aklog, M.D. to Board of Directors |
| 06/11/2020 |
GN
| PAVmed Subsidiary Lucid Diagnostics Receives Preliminary Payment Determination for EsoGuard™ Esophageal DNA Test |
| 06/03/2020 |
GN
| PAVmed Collaborates with Canon on DisappEAR™ Pediatric Ear Tubes |
| 05/11/2020 |
GN
| PAVmed to Hold Business Update Conference Call on May 21, 2020 |
| 04/21/2020 |
GN
| PAVmed Receives FDA 510(k) Clearance for its CarpX™ Minimally Invasive Carpal Tunnel Device |
| 04/09/2020 |
GN
| PAVmed Reports Preliminary Fourth Quarter 2019 Financial Results and Provides Business Update |
| 04/02/2020 |
GN
| PAVmed Subsidiary Lucid Diagnostics' EsoCheck Esophageal Cell Collection Device Receives Prestigious Edison Best New Product Award |
| 03/31/2020 |
GN
| PAVmed Receives $6.3 Million in Gross Proceeds from Completion of November 2019 Financing |
| 03/24/2020 |
GN
| PAVmed to Hold Business Update Conference Call on April 9, 2020 |
|
|
|